The pet tech and care industry has moved from niche to mainstream, transforming into a powerhouse that often outpaces human-focused startups. In 2025, pet startups have attracted record investments, launched groundbreaking products, and driven innovation at a pace that leaves many human health and wellness ventures trailing behind. This article explores why pet-focused startups now earn more and grow faster than many of their human-sector counterparts.
The Explosive Growth of the Pet Industry
In 2025, the global pet care market reached approximately USD 320 billion. Analysts expect this figure to surge past USD 500 billion by 2030, driven by increasing pet ownership and the deepening emotional bond between people and their animals. Pet tech, a critical subset of this market, shows especially strong momentum. The pet tech sector is on track to hit between USD 7.6 billion and USD 9.3 billion in 2025. Projections indicate the market could exceed USD 23 billion by 2032.
Several factors fuel this remarkable growth. Urbanization has created a rise in single-person households, where pets often serve as emotional companions. Pet owners now treat animals as family members, a trend known as “pet humanization.” This mindset shift has sparked demand for smarter, more advanced care solutions—including AI-driven devices, health trackers, telehealth services, and custom nutrition products.
Funding Surges Ahead of Human Health Startups
Pet startups have captured the attention of major investors and venture capital firms. In 2025, funding for pet tech rose by more than 70% compared to 2024. Large conglomerates like Mars, through its Kinship unit, have actively funded and incubated promising pet startups. Venture capitalists, private equity firms, and even public investors have poured money into pet-related businesses, recognizing their potential for quick returns and long-term loyalty from consumers.
One standout is San Francisco-based Loyal, which raised more than USD 150 million. This startup developed an anti-aging pill for senior dogs. The company secured a crucial nod from the U.S. Food and Drug Administration (FDA), with the agency agreeing that Loyal’s drug demonstrates a reasonable expectation of effectiveness. Loyal plans to launch the pill by the end of 2025, pricing it at under USD 100 per month. This marks a major milestone for pet biotech and underscores how pet health innovations can move faster through regulatory hurdles compared to human pharmaceuticals.
Pet Startups Setting New Standards
Several pet startups have outperformed their human-sector peers by offering innovative products that meet urgent market demand.
Loyal leads the field with its anti-aging drug for dogs, setting a precedent for biotech in the pet sector. The company aims to extend canine lifespans while delivering affordable, science-backed care to pet owners eager to support their animals’ health.
Omni, a UK-based brand founded by veterinarians, created a plant-based pet food that addresses allergies and promotes better digestion. The company raised GBP 4 million, with an additional GBP 75,000 earned through a competitive pitch show. Omni doubled its monthly sales within months and now earns about GBP 10 million annually. Its success highlights how alternative proteins and vegan formulas have found firm ground in pet nutrition.
VEA, an AI-driven veterinary diagnostics firm, has gained traction by winning major pet care innovation awards. Its platform provides vets with AI-powered tools to aid in diagnosis and nutrition planning, helping improve the accuracy and speed of pet healthcare.
Technology Driving the Pet Boom
Pet startups have leveraged advanced technologies that once seemed limited to human health. Companies have introduced wearable devices for pets that track activity levels, vital signs, and location. Brands like Whistle, Tractive, and PetPace offer collars and harnesses that monitor everything from heart rate to calorie burn. Pet owners can access this data through mobile apps, giving them peace of mind and actionable insights.
Smart home devices for pets have also surged in popularity. Automatic feeders, water dispensers, litter systems, and pet-safe dryers have turned daily care routines into high-tech experiences. Enabot’s home robots interact with pets remotely, providing both entertainment and surveillance when owners are away.
In pet nutrition, alternative proteins and lab-grown meat options have begun reshaping the food market. Companies that produce cultured meat for pets aim to offer sustainable, cruelty-free alternatives without sacrificing taste or nutrition. Pet owners increasingly choose these options to align their animals’ diets with their ethical and environmental values.
Why Pet Startups Outperform Human-Focused Startups
Pet startups have captured the hearts—and wallets—of consumers by addressing needs that people feel deeply passionate about. Pet owners frequently spend more on their pets’ wellness than on their own. A sense of duty and affection often drives these decisions, especially when pets face health challenges.
Pet-focused ventures enjoy faster approval timelines and lower regulatory costs. The FDA’s veterinary pathways allow innovative treatments and devices to reach market quicker than human equivalents. This factor reduces the time needed to generate returns on investment.
Pet startups often command higher average revenue per user (ARPU). Owners willingly subscribe to monthly plans for supplements, insurance, or digital health services. This loyalty leads to recurring revenue models that many human health startups struggle to achieve.
Investors recognize that pet care aligns perfectly with key technology trends. Artificial intelligence, biotechnology, and telehealth combine in the pet sector to create compelling, scalable businesses. Unlike human health markets, which can feel saturated and overregulated, pet startups enjoy space to innovate and grow.
The Risks on the Horizon
Despite their success, pet startups face several challenges. Consumers have begun to feel the pinch of rising pet-related costs, creating what some analysts describe as “pet debt.” This term reflects how premium products and services strain household budgets, especially in uncertain economic times.
Pet technology must also prove its worth. While gadgets like smart collars and feeders offer convenience, they need to demonstrate measurable benefits to justify their often hefty price tags. Startups that cannot clearly communicate value may struggle to retain customers in a competitive market.
Supply chain issues and inflation have increased manufacturing costs, particularly for electronics-heavy products. Startups that rely on overseas production must find ways to maintain margins while delivering affordable goods to consumers.
What the Future Holds
The pet care sector shows no signs of slowing. Experts forecast that the pet tech market will continue to expand at double-digit growth rates through the next decade. Funding will likely remain strong, with mergers, acquisitions, and public offerings providing exit opportunities for investors.
Startups that integrate wellness, technology, and sustainability into their offerings stand the best chance of long-term success. As consumers look for comprehensive solutions, businesses that deliver end-to-end platforms—from nutrition to healthcare to monitoring—will dominate.
Conclusion
Pet startups have evolved from niche innovators to major players in the global economy. They have earned more than many human-focused startups by creating products that resonate emotionally and practically with consumers. As these companies continue to combine science, technology, and compassion, they will shape the future of pet care—and set new benchmarks for innovation that even human health ventures will aim to follow.
Pet care no longer sits at the fringes of the tech world. It now defines one of the most dynamic and profitable sectors, proving that in the modern economy, pets truly are the new people.
Also Read – Katrina Kaif’s Kay Beauty: Power, Profit & Purpose